{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:43:37Z","timestamp":1760985817609,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12883-019-1370-y","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T10:03:02Z","timestamp":1561370582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Deep brain stimulation for dystonia in Finland during 2007\u20132016"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4886-8285","authenticated-orcid":false,"given":"Rebekka M.","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Scheperjans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eero","family":"Pekkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"1370_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A, Bhatia K, Bressman SB, Delong MR, Fahn S, Fung VS, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28:863\u201373.","journal-title":"Mov Disord"},{"key":"1370_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/mds.21234","volume":"22","author":"D Page","year":"2007","unstructured":"Page D, Butler A, Jahanshahi M. Quality of life in focal, segmental, and generalized dystonia. Mov Disord. 2007;22:341\u20137.","journal-title":"Mov Disord"},{"key":"1370_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/toxins5020249","volume":"5","author":"J Ramirez-Castaneda","year":"2013","unstructured":"Ramirez-Castaneda J, Jankovic J. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins (Basel). 2013;5:249\u201366.","journal-title":"Toxins (Basel)"},{"key":"1370_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40734-016-0034-y","volume":"3","author":"P Termsarasab","year":"2016","unstructured":"Termsarasab P, Thammongkolchai T, Frucht SJ. Medical treatment of dystonia. J Clin Mov Disord. 2016;3:6 eCollection 2016.","journal-title":"J Clin Mov Disord"},{"key":"1370_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1474-4422(14)70143-7","volume":"13","author":"J Volkmann","year":"2014","unstructured":"Volkmann J, Mueller J, Deuschl G, Kuhn AA, Krauss JK, Poewe W, et al. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol. 2014;13:875\u201384.","journal-title":"Lancet Neurol"},{"key":"1370_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/mds.21783","volume":"23","author":"J Mueller","year":"2008","unstructured":"Mueller J, Skogseid IM, Benecke R, Kupsch A, Trottenberg T, Poewe W, et al. Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Mov Disord. 2008;23:131\u20134.","journal-title":"Mov Disord"},{"key":"1370_CR7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1136\/jnnp.2004.057992","volume":"76","author":"TD Halbig","year":"2005","unstructured":"Halbig TD, Gruber D, Kopp UA, Schneider GH, Trottenberg T, Kupsch A. Pallidal stimulation in dystonia: effects on cognition, mood, and quality of life. J Neurol Neurosurg Psychiatry. 2005;76:1713\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1370_CR8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S1474-4422(12)70257-0","volume":"11","author":"J Volkmann","year":"2012","unstructured":"Volkmann J, Wolters A, Kupsch A, Muller J, Kuhn AA, Schneider GH, et al. Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol. 2012;11:1029\u201338.","journal-title":"Lancet Neurol"},{"key":"1370_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/jnnp.2009.174342","volume":"81","author":"F Valldeoriola","year":"2010","unstructured":"Valldeoriola F, Regidor I, Minguez-Castellanos A, Lezcano E, Garcia-Ruiz P, Rojo A, et al. Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study. J Neurol Neurosurg Psychiatry. 2010;81:65\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1370_CR10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1468-1331.2006.01537.x","volume":"13","author":"A Albanese","year":"2006","unstructured":"Albanese A, Barnes MP, Bhatia KP, Fernandez-Alvarez E, Filippini G, Gasser T, et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS\/MDS-ES task force. Eur J Neurol. 2006;13:433\u201344.","journal-title":"Eur J Neurol"},{"key":"1370_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","volume":"18","author":"A Albanese","year":"2011","unstructured":"Albanese A, Asmus F, Bhatia KP, Elia AE, Elibol B, Filippini G, et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol. 2011;18:5\u201318.","journal-title":"Eur J Neurol"},{"key":"1370_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/mds.10377","volume":"18","author":"CL Comella","year":"2003","unstructured":"Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T, Dystonia Study Group. Rating scales for dystonia: a multicenter assessment. Mov Disord. 2003;18:303\u201312.","journal-title":"Mov Disord"},{"key":"1370_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/ene.13255","volume":"24","author":"E Moro","year":"2017","unstructured":"Moro E, LeReun C, Krauss JK, Albanese A, Lin JP, Walleser Autiero S, et al. Efficacy of pallidal stimulation in isolated dystonia: a systematic review and meta-analysis. Eur J Neurol. 2017;24:552\u201360.","journal-title":"Eur J Neurol"},{"key":"1370_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/brain\/awt009","volume":"136","author":"RA Walsh","year":"2013","unstructured":"Walsh RA, Sidiropoulos C, Lozano AM, Hodaie M, Poon YY, Fallis M, et al. Bilateral pallidal stimulation in cervical dystonia: blinded evidence of benefit beyond 5 years. Brain. 2013;136:761\u20139.","journal-title":"Brain."},{"key":"1370_CR15","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00415-008-0798-6","volume":"255","author":"TJ Loher","year":"2008","unstructured":"Loher TJ, Capelle HH, Kaelin-Lang A, Weber S, Weigel R, Burgunder JM, et al. Deep brain stimulation for dystonia: outcome at long-term follow-up. J Neurol. 2008;255:881\u20134.","journal-title":"J Neurol"},{"key":"1370_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1227\/01.neu.0000429841.84083.c8","volume":"73","author":"F Panov","year":"2013","unstructured":"Panov F, Gologorsky Y, Connors G, Tagliati M, Miravite J, Alterman RL. Deep brain stimulation in DYT1 dystonia: a 10-year experience. Neurosurgery. 2013;73:93 discussion 93.","journal-title":"Neurosurgery."},{"key":"1370_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1474-4422(07)70035-2","volume":"6","author":"M Vidailhet","year":"2007","unstructured":"Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Lagrange C, Yelnik J, et al. Bilateral, pallidal, deep-brain stimulation in primary generalised dystonia: a prospective 3 year follow-up study. Lancet Neurol. 2007;6:223\u20139.","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"1370_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mds.23482","volume":"26","author":"H Bronte-Stewart","year":"2011","unstructured":"Bronte-Stewart H, Taira T, Valldeoriola F, Merello M, Marks WJ Jr, Albanese A, et al. Inclusion and exclusion criteria for DBS in dystonia. Mov Disord. 2011;26(Suppl 1):5.","journal-title":"Mov Disord"},{"key":"1370_CR19","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/brain\/awn120","volume":"131","author":"IU Isaias","year":"2008","unstructured":"Isaias IU, Alterman RL, Tagliati M. Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration. Brain. 2008;131:1895\u2013902.","journal-title":"Brain."},{"key":"1370_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000345262","volume":"91","author":"J Witt","year":"2013","unstructured":"Witt J, Starr PA, Ostrem JL. Use of pallidal deep brain stimulation in postinfarct hemidystonia. Stereotact Funct Neurosurg. 2013;91:243\u20137.","journal-title":"Stereotact Funct Neurosurg"},{"key":"1370_CR21","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.brs.2017.07.003","volume":"10","author":"O Jitkritsadakul","year":"2017","unstructured":"Jitkritsadakul O, Bhidayasiri R, Kalia SK, Hodaie M, Lozano AM, Fasano A. Systematic review of hardware-related complications of deep brain stimulation: do new indications pose an increased risk? Brain Stimul. 2017;10:967\u201376.","journal-title":"Brain Stimul"},{"key":"1370_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jocn.2003.10.003","volume":"11","author":"J Yianni","year":"2004","unstructured":"Yianni J, Nandi D, Shad A, Bain P, Gregory R, Aziz T. Increased risk of lead fracture and migration in dystonia compared with other movement disorders following deep brain stimulation. J Clin Neurosci. 2004;11:243\u20135.","journal-title":"J Clin Neurosci"},{"key":"1370_CR23","first-page":"6","volume":"50","author":"MY Oh","year":"2002","unstructured":"Oh MY, Abosch A, Kim SH, Lang AE, Lozano AM. Long-term hardware-related complications of deep brain stimulation. Neurosurgery. 2002;50:6.","journal-title":"Neurosurgery."},{"issue":"Suppl 1","key":"1370_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/mds.23535","volume":"26","author":"M Tagliati","year":"2011","unstructured":"Tagliati M, Krack P, Volkmann J, Aziz T, Krauss JK, Kupsch A, et al. Long-term management of DBS in dystonia: response to stimulation, adverse events, battery changes, and special considerations. Mov Disord. 2011;26(Suppl 1):54.","journal-title":"Mov Disord"},{"key":"1370_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.parkreldis.2017.11.002","volume":"47","author":"KAM Pauls","year":"2018","unstructured":"Pauls KAM, Brockelmann PJ, Hammesfahr S, Becker J, Hellerbach A, Visser-Vandewalle V, et al. Dysarthria in pallidal deep brain stimulation in dystonia depends on the posterior location of active electrode contacts: a pilot study. Parkinsonism Relat Disord. 2018;47:71\u20135.","journal-title":"Parkinsonism Relat Disord"},{"key":"1370_CR26","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s00701-010-0835-y","volume":"152","author":"LJ Bour","year":"2010","unstructured":"Bour LJ, Contarino MF, Foncke EM, de Bie RM, van den Munckhof P, Speelman JD, et al. Long-term experience with intraoperative microrecording during DBS neurosurgery in STN and GPi. Acta Neurochir. 2010;152:2069\u201377.","journal-title":"Acta Neurochir"},{"key":"1370_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/ner.12550","volume":"20","author":"J Perez","year":"2017","unstructured":"Perez J, Gonzalez V, Cif L, Cyprien F, Chan-Seng E, Coubes P. Rechargeable or nonrechargeable deep brain stimulation in dystonia: a cost analysis. Neuromodulation. 2017;20:243\u20137.","journal-title":"Neuromodulation."},{"key":"1370_CR28","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/j.1468-1331.2010.03290.x","volume":"18","author":"C Blahak","year":"2011","unstructured":"Blahak C, Capelle HH, Baezner H, Kinfe TM, Hennerici MG, Krauss JK. Battery lifetime in pallidal deep brain stimulation for dystonia. Eur J Neurol. 2011;18:872\u20135.","journal-title":"Eur J Neurol"},{"key":"1370_CR29","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/jnnp-2016-315504","volume":"88","author":"S Meoni","year":"2017","unstructured":"Meoni S, Fraix V, Castrioto A, Benabid AL, Seigneuret E, Vercueil L, et al. Pallidal deep brain stimulation for dystonia: a long term study. J Neurol Neurosurg Psychiatry. 2017;88:960\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1370_CR30","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/j.1468-1331.2011.03591.x","volume":"19","author":"IM Skogseid","year":"2012","unstructured":"Skogseid IM, Ramm-Pettersen J, Volkmann J, Kerty E, Dietrichs E, Roste GK. Good long-term efficacy of pallidal stimulation in cervical dystonia: a prospective, observer-blinded study. Eur J Neurol. 2012;19:610\u20135.","journal-title":"Eur J Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1370-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1370-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1370-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T23:15:13Z","timestamp":1592867713000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1370-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1370"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1370-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"type":"electronic","value":"1471-2377"}],"subject":[],"published":{"date-parts":[[2019,6,24]]},"assertion":[{"value":"21 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study had research permit from Finnish National Institute for Health and Welfare. The approval of ethics committee was not required because the research was based on hospital records and no patients were contacted.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RO has received a grant from the Finnish Parkinson Foundation. The foundation has no role regarding study design, data collection, analysis, decision to publish and preparation of the manuscript. This does not alter our adherence to BMC Neurology policies on sharing data and materials. Other authors have declared that no competing interests regarding this study exist.RO has received travel support from Abbvie, Allergan and Zambon and participated in clinical trials by Portola Pharmaceuticals and Roche.FS is founder and CEO of NeuroInnovation Oy, has received consulting fees from Herantis Pharma, Orion Pharma, UCB, Renishaw, and LivaNova, lecture fees from Abbvie, UCB, Orion, and Zambon, and travel support from Abbvie, Herantis Pharma, Global Kinetics, UCB, NordicInfu Care, Zambon, and Medtronic, non-financial support from Abbott.EP has received consulting fees from NordicInfu Care, Abbvie, Herantis Pharma, Zambon, lecture fees from Abbott, Abbvie, Lundbeck, Medtronic, and Orion, and travel support from Abbott, Abbvie, Boston Scientific, Herantis Pharma, Medtronic.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}